Volunteer Donate Get Help

In the News

The latest news reports, articles, and stories that may be of importance to leukemia and lymphoma patients, caregivers, and family members.

Posttreatment Needs of Lymphoma Surviors

Published: August 15, 2019

Author: Megan Garlapow, PhD

Source: Cancer Therapy Advisor

Survivors of lymphoma my require individualized supportive care. Although a nurse-led lymphoma survivorship model did not provide clinically significant data, participants in the intervention group reported ... More >>.

Immunotherapy for Treatment Resistant Lymphoma

Published: August 05, 2019

Source: The Mount Sinai Hospital & School of Medicine

Mount Sinai researchers have developed a way to use immunotherapy drugs against treatment-resistant non-Hodgkin's lymphomas for the first time by combining them with stem cell transplantation, an approach th ... More >>.

Important Clue to AML Diagnosis and Treatment

Published: August 01, 2019

Source: Monash University

Around 22,000 people will be diagnosed this year in the U.S. with acute myeloid leukemia (AML), the second most common type of leukemia diagnosed in adults and children, and the most aggressive of the leukem ... More >>.

Cancers According to non-Hodgkin Subtype

Published: July 19, 2019

Author: Susan Moench, PhD, PA-C

Source: Oncology Nurse Advisor

Patients with a subtype of non-Hodgkin lymphoma (NHL) associated with an infectious etiology may be at increased risk of developing particular second solid tumor malignancies also linked to specific types of ... More >>.

Follicular Lymphoma Surveillance Imaging

Published: July 17, 2019

Author: Christina Bennett, MS

Source: Cancer Therapy Advisor

A retrospective cohort study found that surveillance imaging for patients with follicular lymphoma (FL) did not improve their survival outcomes after first relapse, aligning with the results of a prior study ... More >>.

Chemo Drug To Spur Immune System

Published: July 01, 2019

Source: Dana-Farber Cancer Institute

More than 60 years ago, British physician Denis Parsons Burkitt and his associates achieved one of the signal successes in cancer medicine when they cured children in sub-Saharan Africa with a form of lympho ... More >>.

Venetoclax Approved for CLL

Published: June 17, 2019

Source: National Cancer Institute

On May 15, 2019, the Food and Drug Administration (FDA) approved venetoclax (Venclexta) in combination with obinutuzumab (Gazyva) for the initial treatment of adults with chronic lymphocytic leukemia (CLL) o ... More >>.

Targeted Therapy Effective Prior to Chemotherapy

Published: June 04, 2019

Source: MD Anderson Cancer Center

Results of a Phase II clinical trial conducted at The University of Texas MD Anderson Cancer Center revealed that combination targeted therapy, consisting of rituximab, lenalidomide and ibrutinib (RLI), had ... More >>.

Patterns of CLL Growth Identified

Published: June 01, 2019

Source: Dana-Farber Cancer Institute

In patients with chronic lymphocytic leukemia (CLL), the rate of disease growth is apt to follow one of three trajectories: relentlessly upward, steadily level, or something in between, scientists at Dana-Fa ... More >>.

Precision Medicine for AML

Published: May 10, 2019

Source: The Leukemia & Lymphoma Society

Precision medicine centers on giving the right treatment to the right patient at the right time based on their genetic information and other characteristics. We are beginning to crack the code to apply preci ... More >>.

©2015 Stephanie Robinson Foundation | Privacy Policy